Why the study?
Inflammatory responses and lipid metabolism disorders contribute to no-reflow after coronary intervention, prompting investigation into the association between the neutrophil to high-density lipoprotein ratio and no-reflow in STEMI patients after PPCI.
Is the neutrophil to high-density lipoprotein ratio associated with the no-reflow phenomenon in STEMI patients after primary PCI?
Is the neutrophil to high-density lipoprotein ratio associated with the no-reflow phenomenon in STEMI patients after primary PCI?
The neutrophil to high-density lipoprotein ratio is an independent risk factor and potential diagnostic marker for the no-reflow phenomenon in STEMI patients undergoing primary PCI.
No takes yet. Share an insight, caveat, or question.
May flag higher no-reflow risk after PPCI in STEMI; leaves open incremental predictive value in prospective cohorts.
Hu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: